![Leila Nicolas](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Leila Nicolas
Direttore/Membro del Consiglio presso
ACTICOR BIOTECH
Profilo
Leila Nicolas is currently working as an Investment Director at GO Capital SAS, as a Director at Acticor Biotech SAS, as a Director at VitaDx International SAS, and as a Director at PHAXIAM Therapeutics SA. Her former positions include being a Director at Graftys SA from 2019 to 2020, a Director at VitamFero SA from 2014 to 2018, a Director at Horama SA, a Product Manager at Bayer Pharma AG, and a Member-Supervisory Board at Pherecydes Pharma SA.
Posizioni attive di Leila Nicolas
| Società | Posizione | Inizio |
|---|---|---|
| ACTICOR BIOTECH | Direttore/Membro del Consiglio | - |
| PHAXIAM THERAPEUTICS S.A. | Direttore/Membro del Consiglio | 23/06/2023 |
GO Capital SAS
 GO Capital SAS Investment ManagersFinance GO Capital invests in companies located in France. The firm targets companies operating in the fields of health, digital, cleantech and marine economy. It participates in seed and early stage capital requirements. The firm acquires minority interest. | Investitore di Private Equity | 01/01/2015 |
VitaDx International SAS
 VitaDx International SAS Medical SpecialtiesHealth Technology Develops a solution for early diagnosis of bladder cancer | Direttore/Membro del Consiglio | 01/01/2017 |
Precedenti posizioni note di Leila Nicolas
| Società | Posizione | Fine |
|---|---|---|
Graftys SA
 Graftys SA Medical SpecialtiesHealth Technology Manufactures bone graft substitutes for orthopedic surgery | Direttore/Membro del Consiglio | 01/01/2020 |
VitamFero SA
 VitamFero SA Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products and vaccines | Direttore/Membro del Consiglio | 01/01/2018 |
Bayer Pharma AG
 Bayer Pharma AG Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | - |
Horama SA
 Horama SA BiotechnologyHealth Technology Develops gene therapies for eye diseases | Direttore/Membro del Consiglio | - |
| PHERECYDES PHARMA | Direttore/Membro del Consiglio | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
14
Relazioni di 1° grado
9
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 9 |
|---|---|
GO Capital SAS
GO Capital SAS Investment ManagersFinance GO Capital invests in companies located in France. The firm targets companies operating in the fields of health, digital, cleantech and marine economy. It participates in seed and early stage capital requirements. The firm acquires minority interest. | Finance |
Bayer Pharma AG
Bayer Pharma AG Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Graftys SA
Graftys SA Medical SpecialtiesHealth Technology Manufactures bone graft substitutes for orthopedic surgery | Health Technology |
VitamFero SA
VitamFero SA Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products and vaccines | Health Technology |
Pherecydes Pharma SA
 Pherecydes Pharma SA Pharmaceuticals: MajorHealth Technology Specializes in nano technologies for pharmaceutical purposes | Health Technology |
Horama SA
Horama SA BiotechnologyHealth Technology Develops gene therapies for eye diseases | Health Technology |
Acticor Biotech SAS
 Acticor Biotech SAS Miscellaneous Commercial ServicesCommercial Services Engages in research and development of pharmaceutical products | Commercial Services |
VitaDx International SAS
VitaDx International SAS Medical SpecialtiesHealth Technology Develops a solution for early diagnosis of bladder cancer | Health Technology |
PHAXIAM Therapeutics SA
 PHAXIAM Therapeutics SA Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops red blood cell-based therapeutics for severe forms of cancer & orphan diseases | Health Technology |
